# Opioid, HIV and Immune System

> **NCT04304768** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Miami** · enrollment: 400 (estimated)

## Conditions studied

- Immune Defect

## Interventions

- **BIOLOGICAL:** Fluzone Quadrivalent

## Key facts

- **NCT ID:** NCT04304768
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-18
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04304768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04304768, "Opioid, HIV and Immune System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04304768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*